![Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-021-00897-2/MediaObjects/12894_2021_897_Fig2_HTML.png)
Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text
![Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41391-017-0008-7/MediaObjects/41391_2017_8_Fig1_HTML.jpg)
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases
![Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41391-017-0008-7/MediaObjects/41391_2017_8_Fig2_HTML.jpg)
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting | Prostate Cancer and Prostatic Diseases
![Frontiers | Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy Frontiers | Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy](https://www.frontiersin.org/files/Articles/565382/fonc-10-565382-HTML/image_m/fonc-10-565382-t001.jpg)
Frontiers | Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
![Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL - ScienceDirect Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1607551X17307350-gr1.jpg)
Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL - ScienceDirect
![PDF] Performance Evaluation of the Total ProstateSpecific Antigen (PSA), Free PSA, and [–2]proPSA Assay for Calculation of the Prostate Health Index Using the UniCel DxI 800 Analyzer | Semantic Scholar PDF] Performance Evaluation of the Total ProstateSpecific Antigen (PSA), Free PSA, and [–2]proPSA Assay for Calculation of the Prostate Health Index Using the UniCel DxI 800 Analyzer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e0e968c3e788496f97e5a3845a508bb307c7c972/3-Table1-1.png)
PDF] Performance Evaluation of the Total ProstateSpecific Antigen (PSA), Free PSA, and [–2]proPSA Assay for Calculation of the Prostate Health Index Using the UniCel DxI 800 Analyzer | Semantic Scholar
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml | PLOS ONE
![Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - The Lancet Oncology Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34ea5efa-66f4-44e5-9c65-a008457e5e1f/gr1.jpg)